XORTX Therapeutics XRTX
NASDAQ XRTX
$1.70 -0.03 (-1.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Change in Accured Expenses (2020 - 2026)

Updated

XORTX Therapeutics' Change in Accured Expenses was -$289,387 in the quarter ended Jun 30, 2026, compared with -$30,160 a year earlier.

Analysis

XORTX Therapeutics (XRTX) Change in Accured Expenses (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, XORTX Therapeutics' Change in Accured Expenses was $13,788 through Jun 30, 2026; for the year ended Dec 31, 2025, it came in at $235,949.

  • Change in Accured Expenses shows a five-year compound annual growth rate of -4.8% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Change in Accured Expenses was -$134,447 in the year ended Dec 31, 2024, -$1.19 million in the year ended Dec 31, 2023, $892,265 in the year ended Dec 31, 2022 and -$259,323 in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Change in Accured Expenses since the quarter ended Mar 31, 2023.
  • Per Business Quant data, XRTX's Change in Accured Expenses in the three quarters before the quarter ended Jun 30, 2026 was $305,375 (quarter ended Mar 31, 2026), -$2,299 (quarter ended Dec 31, 2025) and $99.00 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 XORTX Therapeutics 1.61 Mn -1.69 Mn - -289,387.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -289,387.00
Mar 31, 2026 305,375.00
Dec 31, 2025 -2,299.00
Sep 30, 2025 99.00
Jun 30, 2025 -30,160.00
Mar 31, 2025 268,309.00
Dec 31, 2024 -178,792.00
Sep 30, 2024 -111,882.00
Jun 30, 2024 110,853.00
Mar 31, 2024 45,374.00
Dec 31, 2023 -271,698.00
Sep 30, 2023 165,253.00
Jun 30, 2023 -180,175.00
Mar 31, 2023 -907,816.00
Dec 31, 2022 86,798.34
Sep 30, 2022 714,503.99
Jun 30, 2022 43,017.16
Mar 31, 2022 125,245.54
Dec 31, 2021 -13,355.81
Sep 30, 2021 228,960.68
API Access

XORTX Therapeutics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=XRTX&period=max&api_key=YOUR_API_KEY